{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:11:06Z","timestamp":1792631466320,"version":"4.5.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The neonatal Fc receptor (FcRn) is important for numerous cellular processes that involve antibody recycling and trafficking. A major function of FcRn is IgG recycling and half-life prolongation, and FcRn blockade results in a reduction of autoantibodies in IgG-mediated autoimmune diseases. In epithelial cells, FcRn functions in processes different from IgG recycling, such as antibody transcytosis in intestinal cells. In pemphigus vulgaris, an autoimmune disease of the epidermis, IgG autoantibodies directed against desmosomal adhesion proteins, especially desmoglein-3 and -1, cause loss of keratinocyte adhesion. We have previously demonstrated that FcRn blockade with efgartigimod, a human Fc fragment with enhanced FcRn binding, significantly reduces the keratinocyte monolayer fragmentation caused by anti-desmoglein-3 antibodies. This points to a direct function of FcRn in keratinocytes, beyond IgG recycling, but the mechanisms have not yet been elucidated in detail. Here, we show that FcRn binding is required for the full pathogenicity of recombinant anti-desmoglein-3 antibodies in keratinocytes, and that antibodies that exhibit enhanced or reduced FcRn affinity due to targeted substitutions in their Fc region, as well as F(ab\u2019)2 fragments not binding to FcRn display different degrees of pathogenicity. Blockade of FcRn by efgartigimod only shows a protective effect on keratinocyte adhesion against antibodies capable of binding to FcRn. Furthermore, antibody-induced degradation of desmoglein-3 in keratinocytes does not depend on FcRn, demonstrating that desmoglein-3 degradation and acantholysis are functionally disconnected processes. Our data suggest that the role of FcRn in autoimmune diseases is likely to be versatile and cell-type dependent, thus stressing the importance of further studies on FcRn function in autoimmune diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1473637","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T12:41:38Z","timestamp":1728564098000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Binding to the neonatal Fc receptor enhances the pathogenicity of anti-desmoglein-3 antibodies in keratinocytes"],"prefix":"10.3389","volume":"15","author":[{"given":"Anna","family":"Zakrzewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Vanderheyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yad","family":"Galaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Feldhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Sips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Brinkhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva","family":"Tikkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(66)92190-8","article-title":"The transmission of immunity from mother to young and the catabolism of immunoglobulins","volume":"2","author":"Brambell","year":"1966","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00821-1","article-title":"The therapeutic age of the neonatal Fc receptor","volume":"23","author":"Pyzik","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01540","article-title":"The neonatal fc receptor (FcRn): A misnomer","volume":"10","author":"Pyzik","year":"2019","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/372336a0","article-title":"Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor","volume":"372","author":"Burmeister","year":"1994","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/372379a0","article-title":"Crystal structure of the complex of rat neonatal Fc receptor with Fc","volume":"372","author":"Burmeister","year":"1994","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0923-2494(96)89647-7","article-title":"The structure and evolution of FcRn","volume":"147","author":"Simister","year":"1996","journal-title":"Res Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/337184a0","article-title":"An Fc receptor structurally related to MHC class I antigens","volume":"337","author":"Simister","year":"1989","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1008353","article-title":"The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity","volume":"7","author":"Abdiche","year":"2015","journal-title":"MAbs"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2006.00457.x","article-title":"Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor","volume":"7","author":"Tesar","year":"2006","journal-title":"Traffic"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1038\/s41467-022-33764-1","article-title":"The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement","volume":"13","author":"Brinkhaus","year":"2022","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00230-1","article-title":"Crystal structure at 2.8 A of an FcRn\/heterodimeric Fc complex: mechanism of pH-dependent binding","volume":"7","author":"Martin","year":"2001","journal-title":"Mol Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1021\/bi000749m","article-title":"Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,)","volume":"39","author":"West","year":"2000","journal-title":"Biochemistry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6","article-title":"Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn","volume":"29","author":"Kim","year":"1999","journal-title":"Eur J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.537563","article-title":"Structural insights into neonatal Fc receptor-based recycling mechanisms","volume":"289","author":"Oganesyan","year":"2014","journal-title":"J Biol Chem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1021\/bi00045a005","article-title":"Analysis of the pH dependence of the neonatal Fc receptor\/immunoglobulin G interaction using antibody and receptor variants","volume":"34","author":"Raghavan","year":"1995","journal-title":"Biochemistry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1304365","article-title":"Impact of structural modifications of IgG antibodies on effector functions","volume":"14","author":"Damelang","year":"2023","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1038\/s41467-019-13108-2","article-title":"An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence","volume":"10","author":"Lee","year":"2019","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000451","article-title":"Neonatal fc receptor inhibitor therapeutics in neuromuscular disease","volume":"24","author":"Jaffry","year":"2023","journal-title":"J Clin Neuromuscul Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01460-5","article-title":"Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"402","author":"Broome","year":"2023","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007600","article-title":"Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis","volume":"92","author":"Howard","year":"2019","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97911","article-title":"Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans","volume":"128","author":"Ulrichts","year":"2018","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003780","article-title":"Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model","volume":"187","author":"Patel","year":"2011","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1143","article-title":"Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels","volume":"23","author":"Vaccaro","year":"2005","journal-title":"Nat Biotechnol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cells11060942","article-title":"Stabilization of keratinocyte monolayer integrity in the presence of anti-desmoglein-3 antibodies through fcRn blockade with efgartigimod: novel treatment paradigm for pemphigus","volume":"11","author":"Zakrzewicz","year":"2022","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133113","article-title":"Immortalized human hTert\/KER-CT keratinocytes a model system for research on desmosomal adhesion and pathogenesis of pemphigus vulgaris","volume":"20","author":"Beckert","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax9586","article-title":"Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex-mediated immune responses","volume":"5","author":"Blumberg","year":"2019","journal-title":"Sci Adv"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1323159","article-title":"Affinity of human IgG subclasses to mouse Fc gamma receptors","volume":"9","author":"Dekkers","year":"2017","journal-title":"MAbs"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24185","article-title":"Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display","volume":"115","author":"Payne","year":"2005","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.4.2170","article-title":"Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3","volume":"170","author":"Tsunoda","year":"2003","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/13.12.1551","article-title":"Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies","volume":"13","author":"Ober","year":"2001","journal-title":"Int Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.5.3266","article-title":"MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells","volume":"166","author":"Zhu","year":"2001","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-007-0734-0","article-title":"The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases","volume":"299","author":"Sitaru","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00708.x","article-title":"IgG4 as the predominant autoantibody in sera from patients with active state of pemphigus vulgaris","volume":"18","author":"Ayatollahi","year":"2004","journal-title":"J Eur Acad Dermatol Venereology: JEADV"},{"key":"B36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0923-1811(00)00158-4","article-title":"Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus","volume":"26","author":"Futei","year":"2001","journal-title":"J\u00a0Dermatol science"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1553","article-title":"Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo","volume":"27","author":"Labrijn","year":"2009","journal-title":"Nat Biotechnol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00871-z","article-title":"The unique properties of IgG4 and its roles in health and disease","volume":"23","author":"Rispens","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ncomms1608","article-title":"Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential","volume":"2","author":"Stapleton","year":"2011","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01788","article-title":"The p.Arg435His variation of igG3 with high affinity to fcRn is associated with susceptibility for pemphigus vulgaris-analysis of four different ethnic cohorts","volume":"9","author":"Recke","year":"2018","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4408","article-title":"Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence","volume":"85","author":"Mascaro","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114426","article-title":"Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb\/c mice","volume":"85","author":"Rock","year":"1990","journal-title":"J Clin Invest"},{"key":"B43","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.ajpath.2011.04.015","article-title":"Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris","volume":"179","author":"Tsunoda","year":"2011","journal-title":"Am J pathology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2024.05.013","article-title":"FcRn inhibition reduces bullous pemphigoid anti-basement membrane zone IgG deposition and blistering in 3D human skin equivalents","volume":"14","author":"Bao","year":"2024","journal-title":"J Invest Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e13-04-0174","article-title":"Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubules","volume":"24","author":"Weflen","year":"2013","journal-title":"Mol Biol Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.863095","article-title":"FcRn antagonism leads to a decrease of desmoglein-specific B cells: secondary analysis of a phase 2 study of efgartigimod in pemphigus vulgaris and pemphigus foliaceus","volume":"13","author":"Maho-Vaillant","year":"2022","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.04.031","article-title":"Safety, tolerability, and activity of ALXN1830 targeting the neonatal fc receptor in chronic pemphigus","author":"Werth","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.701809","article-title":"Autoantibody-specific signalling in pemphigus","volume":"8","author":"Schmitt","year":"2021","journal-title":"Front Med (Lausanne)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1473637\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T12:41:41Z","timestamp":1728564101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1473637\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2024.1473637"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1473637","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"article-number":"1473637"}}